A Study of the Effect on Obesity in Taeeumin Animal-experimental Model Induced Lung Fibrosis with Bleomycin

Bleomycin으로 유발한 폐약(肺弱) 태음인 동물 모델에서의 비만에 대한 영향 평가

Kim, Yoonha;Park, Junghwan;Kwak, Jinyoung;Park, Jungmi;Ahn, Taek won

  • Received : 2016.04.17
  • Accepted : 2016.06.22
  • Published : 2016.06.30


Objectives The objective of this study is to develop a taeeumin animal-experimental model induced lung fibrosis with Bleomycin and evaluate the effect on obesity in this animal-experimental model.Methods The subjects were divided into 3 groups : normal group, high fat diet(HFD) control group, and HFD group administered with bleomycin(n=10 per group). To develop taeeumin animal-experimental model with reduced respiratory metabolism, 8-week-old C57BL/6 mice were administered with 0.03ml solution of bleomycin 1U/ml dissolved in distilled water, intratracheal(IT), once. Then, the HFD control group and the experimental group were fed with high fat diet for 6 weeks. Airway hyperresponsiveness(AHR) to methacholine was measured at the 1st and 3rd week after bleomycin was administered. Food intake and body weight were measured at regular time weekly. After the final experiment, blood was gathered by cardiac puncture for bloodchemical examination and organs(liver, fatty tissue) were remoed, weighted, and mRNA was analyzed.Results and Conclusions Through the experiment, it was found that Bleomycin induced Taeeumin animal-experimental models have leptin resistace. In the experimental group administered with Bleomycin, fatty acid synthesizing gene expression increased and energy metabolizing gene expression decreased. As mRNA expression of adiponectin decreased, it was found that Taeeuim animal-experimental model is susceptible to metabolic syndrome and cardiovascular diseases.


Taeeumin;Obesity;Leptin;Adiponectin;Bleomycin;Animal-experimental model


  1. Lee JM. Dongeisusebowon. Seoul: Daesungmoonhwasa. 1997;1:5, 4:1,10,29-32. (Korean)
  2. Lee JM. Dongeisusebowon. 2nd rev. Seoul: Yeogang. 2003:36,278. (Korean)
  3. Dept. of Sasang Constitutional Medicine. All colleges of Korean med. in Korea(compilation). The revised and enlarged Sasang Constitutional Medicine. Seoul: Jipmoondang. 2012:131. (Korean)
  4. Lee JH, Lee EJ, Koh BH. A study on the schematic organization of the sub-classification system of the Taeeumin symptomatology. J Sasang Constitut Med. 2011:23(1):63-78. (Korean)
  5. Moon SH, Sin SH, Kim HJ, Kim JY. A relationship of the obesity and body composition analysis by Sasang constitution. J Oriental Rehab Med. 2002;12(4):1-10. (Korean)
  6. Kim DR. A study on 4 type constitution and life character of obese patients. J of Const Med. 1997;9(1): 303-13. (Korean)
  7. Kim DR, Baek TH. Clinical Study on the Relationship of Sasang constitution and Obesity. J Sasang Constitut Med. 1996;8(1):319-35. (Korean)
  8. Ryu SM, Shin SU, Kim KS, Moon JS, Yoon YS. Analysis of obesity degree and comparision of weight control program among Sasang constitution. Journal of Korean Oriental Association for Study of Obesity. 2005;5(1):21-9. (Korean)
  9. Adamson IYR, Bowden DH. The pathogenesis of bleomycin induced pulmonary fibrosis in mice. Am J Pathol. 1974;77:185-97.
  10. Chandler DB, Hyde DM, Gin SN. Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters. Am J Pathol. 1996;112:981-92.
  11. Vanhee D, Gosset P, Boitelle A, Wallaert B, Tonnel AB. Cytokines and cytokine network in silicosis and coal workers' pneumoconiosis. Eur Respir J 1995.8: 834-42.
  12. Zhang K, Gharaee Kermani M, McGarry B, Remick D, Phan SH. TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis. J Immunol. 1997;158:954-9.
  13. Huaux F, Lardot C, Arras M, Delos M, Many MC, Coutelier JP, et al. Lung fibrosis induced by silica particles in NMRI mice is associated with an upregulation of the p40 subunit of interleukin-12 and Th-2 manifestations. Am J Respir Cell Mol Biol. 1999;20: 561-72.
  14. Lee SG, Kwak CK, Lee EJ, Koh BH, Song IB. The study on the upgrade of QSCCII(II);the study on the re-validity of QSCCII. J Sasang Constitut Med. 2003;15:39-50. (Korean)
  15. Pak YS, Kim JS, Lee JH, Lee EJ, Koh BH. Association between Sasang Constitution, Impaired Lung Function and Metabolic Syndrome among Middle-aged Adults in Korea. J Sasang Constitut Med 2013;25(3):180-194. (Korean)
  16. Muoio DM, Dohm GL. Peripheral metabolic actions of leptin. Best Pract Res Clin Endocrinol Metab. 2002;16(4):653-66.
  17. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;316: 129-139.
  18. Unal M, Eskandari G, Muslu N, Pata YS, Akbas Y. Serum leptin levels in patients with allergic rhinitis. Otolaryngol Head Neck Surg. 2006;134:331-333.
  19. Guler N, Kirerleri E, Ones U, Tamay Z, Salmayenli N, Darendeliler F. Leptin: does it have any role in childhood asthma? J Allergy Clin Immunol. 2004;114: 254-259.
  20. Bruno A, Chanez P, Chiappara G, Siena L, Giammanco S, Gjomarkaj M, et al. Does leptin play a cytokine-like role within the airways of COPD patients? Eur Respir J. 2005;26:398-405.
  21. Guven M, Bulut Y, Aladag I, Yelken K, Erdogan H. Serum leptin levels in patients with nasal polyposis. J Laryngol Otol. 2008;122:590-592.
  22. Lee SM, Choi HJ, Oh CH, Oh JW, Han JS. Leptin Increases TNF-α Expression and Production through Phospholipase D1 in Raw 264.7 Cells. PLoS One. 2014;9(7):e102373.
  23. Björnholm M, Münzberg H, Leshan RL, Villanueva EC, Bates SH, Louis GW, et al. Mice lacking inhibitory leptin receptor signals are lean with normal endocrine function. J Clin Invest 2007;117:1354-60.
  24. Lantz KA, Hart SG, Planey SL, RoitmanMF, Ruiz-White IA, Wolfe HR, et al. Inhibition of PTP1B by Trodusquemine (MSI‐1436) Causes Fat‐specific Weight Loss in Diet‐induced Obese Mice. Obesity (Silver Spring) 2010;18:1517-23.
  25. Steinberg GR, Smith AC, van Denderen BJW, Chen Z, Murthy S, Campbell DJ, et al. AMP-activated protein kinase is not down-regulated in human skeletal muscle of obese females. J Clin Endocrinol Metab. 2004;89:4575-4580.
  26. Cintra DE, Ropelle ER, Moraes JC, Pauli JR, Morari J, Souza CT, et al. Unsaturated fatty acids revert diet-induced hypothalamic inflammation in obesity. PLoS One. 2012;7:e30571.
  27. Ozcan L, Ergin AS, Lu A, Chung J, Sarkar S, Nie D, et al. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 2009;9:35-51.
  28. Ziemke F, Mantzoros CS. Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr. 2010;91:258S-61S.
  29. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001;7(8):947-953.
  30. Matsuzawa Y. Establishment of a concept of visceral fat syndrome and discovery of adiponectin. Proc Jpn Acad 2010;86:131-140.
  31. Matsuzawa Y. Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease. Atheroscler Suppl. 2005;6:7-14.
  32. Marceau P, Biron S, Hould FS, Marceau S, Simard S, Kral JG, et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab. 1999;84(5):1513-1517.
  33. Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997; 89(3):331-340.

Cited by

  1. A Study of the Effect on Obesity and dyslipidemia in Kidney-hypofunction Animal Model Induced by Unilateral Ureteral Obstruction vol.39, pp.2, 2018,